NCT06061588Completed
"Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches"
Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches: Randomized Observational Study
Source: ClinicalTrials.gov · Last updated 6 May 2024
Brief summary (registry, in English)
The primary objective of this research is to investigate the effects of virtual reality technology on the treatment of migraine-type headaches and assess how this technology may impact the severity, frequency, and duration of headaches.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 140 (actual)
- First submitted
- 23 Sept 2023
- Start date
- 15 Sept 2023
- Primary completion date
- 10 Mar 2024
- Lead sponsor
- Ankara City Hospital Bilkent
- Diseases
- Migraine
- NCT number
- NCT06061588
What you commit to
- Study type: Interventional
- Participants enrolled: 140
- From 15 Sept 2023 to the primary completion date, 10 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having taken analgesics within 8 hours prior to examination
Other illness
- With a known history of adverse reactions to NSAIDs
- Individuals with advanced systemic illness
- Those with malignancies
- Patients with chronic liver and kidney disease
- Using sedative and analgesic neuro-psychiatric drugs
- With a history of psychological and neurological diseases
Age
- Under 18 years of age or over 65 years of age
Other
- Not willing to participate in the study
- Displaying vital signs outside of normal limits
- Unable to determine the severity of pain on the VAS
- Scoring 50 mm or lower on the VAS
- Pregnant individuals
Who the study is looking for
- 18 years of age or older
- Under the age of 65
- Willing to participate in the study
- Previously diagnosed with migraine
- Marking a VAS score of 50 or higher
- Not considered for any additional preliminary diagnosis
- No known adverse history to the active ingredient of the medication to be used
- Conscious
- Cooperatively oriented
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.